Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melinda J Gooderham

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Psoriasis (Auckland, N.Z.)|March 25, 2021
Phosphodiesterase-4 Inhibition in PsoriasisMilica Milakovic, Melinda J Gooderham
Expert Review of Clinical Immunology|November 23, 2021
TYK2 inhibition: changing the treatment landscape for psoriasis?Abrahim Abduelmula, Melinda J Gooderham
Core Evidence|March 6, 2018
Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitisPanteha Eshtiaghi, Melinda J Gooderham
Journal of Cutaneous Medicine and Surgery|January 24, 2022
Achenbach Syndrome (Paroxysmal Finger Hematoma)Claire Chiang, Melinda J Gooderham
Journal of Cutaneous Medicine and Surgery|March 21, 2023
Long-Term Multiple Center Experience in Treating Plaque Psoriasis With Halobetasol Propionate 0.01% and Tazarotene 0.045% LotionAbrahim Abduelmula, Melinda J Gooderham
Journal of Cutaneous Medicine and Surgery|November 16, 2017
A Guide to Topical Vehicle FormulationsJulia N Mayba, Melinda J Gooderham
Journal of Cutaneous Medicine and Surgery|May 11, 2022
Practice Patterns Around the Management of Atopic Dermatitis in 2018 and 2020Melinda J Gooderham, Chih-Ho Hong
Journal of Cutaneous Medicine and Surgery|November 16, 2016
Real-World Experience With Apremilast in Treating PsoriasisJulia N Mayba, Melinda J Gooderham
Journal of Cutaneous Medicine and Surgery|March 17, 2017
Review of Atopic Dermatitis and Topical TherapiesJulia N Mayba, Melinda J Gooderham
Pharmaceutics|January 23, 2024
Phosphodiesterase-4 Inhibition in the Management of PsoriasisErika L Crowley, Melinda J Gooderham
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Psoriasis (Auckland, N.Z.)|March 25, 2021
Phosphodiesterase-4 Inhibition in PsoriasisMilica Milakovic, Melinda J Gooderham
Expert Review of Clinical Immunology|November 23, 2021
TYK2 inhibition: changing the treatment landscape for psoriasis?Abrahim Abduelmula, Melinda J Gooderham
Core Evidence|March 6, 2018
Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitisPanteha Eshtiaghi, Melinda J Gooderham
Journal of Cutaneous Medicine and Surgery|January 24, 2022
Achenbach Syndrome (Paroxysmal Finger Hematoma)Claire Chiang, Melinda J Gooderham
Journal of Cutaneous Medicine and Surgery|March 21, 2023
Long-Term Multiple Center Experience in Treating Plaque Psoriasis With Halobetasol Propionate 0.01% and Tazarotene 0.045% LotionAbrahim Abduelmula, Melinda J Gooderham
Journal of Cutaneous Medicine and Surgery|November 16, 2017
A Guide to Topical Vehicle FormulationsJulia N Mayba, Melinda J Gooderham
Journal of Cutaneous Medicine and Surgery|May 11, 2022
Practice Patterns Around the Management of Atopic Dermatitis in 2018 and 2020Melinda J Gooderham, Chih-Ho Hong
Journal of Cutaneous Medicine and Surgery|November 16, 2016
Real-World Experience With Apremilast in Treating PsoriasisJulia N Mayba, Melinda J Gooderham
Journal of Cutaneous Medicine and Surgery|March 17, 2017
Review of Atopic Dermatitis and Topical TherapiesJulia N Mayba, Melinda J Gooderham
Pharmaceutics|January 23, 2024
Phosphodiesterase-4 Inhibition in the Management of PsoriasisErika L Crowley, Melinda J Gooderham
Pageof 12